Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems

Clinical Rheumatology

Volumn 35, Issue 10, 2016, Pages 2381-2385

  Pineda, Carlos ^a   Muñoz Louis, Roberto ^b   Caballero Uribe, Carlo V ^c   Viasus, Diego ^c  

^a INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^b Hospital Docente Padre Billini   (Dominican Republic)

^c UNIVERSIDAD DEL NORTE   (Colombia)

Author keywords

Arbovirus; Arthritis; Chikungunya; Epidemiology; Health care systems; Outbreak

Indexed keywords

BIOLOGICAL MARKER; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENTEEISM; AMERICAN; ARTHRALGIA; ARTICLE; CHIKUNGUNYA; CHRONIC ARTHRITIS; CLIMATE CHANGE; CLINICAL FEATURE; HEALTH CARE SYSTEM; HUMAN; INFECTION PREVENTION; NECK PAIN; NONHUMAN; PATHOPHYSIOLOGY; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOLOGY; UNITED STATES; CHIKUNGUNYA FEVER; EPIDEMIC; INCIDENCE; SOUTH AND CENTRAL AMERICA;

CHIKUNGUNYA FEVER; DISEASE OUTBREAKS; HUMANS; INCIDENCE; LATIN AMERICA; RHEUMATOLOGY;

EID: 84983395779     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3390-y     Document Type: Article

References (42)

1. Fauci AS, Morens DM (2012) The perpetual challenge of infectious diseases. N Engl J Med 366(5):454–461. doi:10.1056/NEJMra1108296
2. Lima-Camara TN (2016) Emerging arboviruses and public health challenges in Brazil. Rev Saude Publica 50. doi: 10.1590/S1518-8787.2016050006791
3. Mahendradas P, Avadhani K, Shetty R (2013) Chikungunya and the eye: a review. J Ophthalmic Inflam Infect 3(1):35. doi:10.1186/1869-5760-3-35
4. Thiberville SD, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, de Lamballerie X (2013) Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antivir Res 99(3):345–370. doi:10.1016/j.antiviral.2013.06.009
5. Robillard PY, Boumahni B, Gérardin P, et al. (2006) Vertical maternal fetal transmission of the Chikungunya virus. Ten cases among 84 pregnant women. Presse Med 35:785–788
6. Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–53. I. Clinical features. Trans R Soc Trop Med Hyg 49(1):28–32
7. Lumsden WH (1955) An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–53. II. General description and epidemiology. Trans R Soc Trop Med Hyg 49(1):33–57
8. Weaver SC, Forrester NL (2015) Chikungunya: evolutionary history and recent epidemic spread. Antivir Res 120:32–39. doi:10.1016/j.antiviral.2015.04.016
9. Staples JE, Breiman RF, Powers AM (2009) Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 49(6):942–948. doi:10.1086/605496
10. Simon F, Parola P, Grandadam M, et al. (2007) Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine 86(3):123–137. doi:10.1097/MD/0b013e31806010a5
11. World Health Organization. Chikungunya (2016) Fact sheet N° 327. Updated (April 2016) http://www.who.int/mediacentre/factsheets/fs327/en/. (Accessed Jul 2016
12. Organización Panamericana de la Salud/ Organización Mundial de la Salud (2016) Alerta Epidemiológica. Fiebre por Chikungunya. 9 de diciembre del 2013. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=23807&Itemid (Accessed Jul 2016)
13. Alfaro-Toloza P, Clouet-Huerta DE, Rodríguez-Morales AJ (2015) Chikungunya, the emerging migratory rheumatism. Lancet Infect Dis 15(5):510–512. doi:10.1016/S1473-3099(15)70160-X
14. Jiménez-Canizales CE, Medina-Gaitán DA, Mondragón-Cardona ÁE, Rodríguez-Morales AJ (2015) From imported to an endemic disease: impact of Chikungunya virus disease in the hospital epidemiology, Tolima, Colombia, 2014-2015. Recent Pat Antiinfect Drug Discov 10(1):64–66
15. Rodríguez-Morales AJ, Bedoya-Árias JE, Ramírez-Jaramillo V, Montoya-Árias CP, Guerrero-Matituy EA, Cárdenas-Giraldo EV (2015) Mapping chikungunya fever in municipalities of one coastal Department of Colombia (Sucre) using geographic information system (GIS) during 2014 outbreak: implications for travel advice. Travel Med Infect Dis 13(3):256–258. doi:10.1016/j.tmaid.2015.05.007
16. Boletín especial (2014) MISP # 13. 20–08. http://www.paho.org/dor/images/stories/archivos/chikungunya/boletin_chikv_no-3_2014_6_09.pdf (Accessed Jun 2016)
17. Boletín Epidemiológico Semanal (Semana epidemiológica número 17 de 2015). Available at: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2015%20Boletin%20epidemiologico%20semana%2017.pdf (Accessed Aug 2015)
18. Centers for Disease Control and Prevention (2015) Chikungunya virus http://www.cdc.gov/chikungunya/geo/united-states.html (Accessed Aug 2015
19. Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 372(13):1231–1239. doi:10.1056/NEJMra1406035
20. Ali Ou Alla S, Combre B (2011) Arthritis after infection with Chikungunya virus. Best Pract Res Clin Rheumatol 25:337–346. doi:10.1016/j.berh.2011.03.005
21. Win MK, Chow A, Dimatatac F (2010) Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 49(2):111–114. doi:10.1016/j.jcv.2010.07.004
22. Ganu MA, Ganu AS (2011) Post-Chikungunya chronic arthritis—our experience with DMARDs over two year follow up. J Assoc Physicians India 59:83–86
23. Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7(3):e2137. doi:10.1371/journal.pntd.0002137
24. Miner JJ, Aw-Yeang HX, Fox JM, et al. (2015) Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 67(5):1214–1220. doi:10.1002/art.39027
25. Bouquillard E, Combe B (2009) Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis 68(9):1505–1506. doi:10.1136/ard.2008.097626
26. Rodriguez-Morales AJ, Cardona-Ospina JA, Villamil-Gómez W, Paniz-Mondolfi AE (2015) How many patients with post-Chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? Rheumatol Int 35(12):2091–2094. doi:10.1007/s00296-015-3302-5
27. Rosario V, Muñoz-Louis R, Valdéz T, et al. (2015) Chikungunya infection in the general population and in the patient with rheumatoid arthritis on biological therapy. Clin Rheumatol 34(7):1285–1287. doi:10.1007/s10067-015-2979-x
28. Abstracts PANLAR (2016) J Clin Rheumatol 3(22):108–163. doi:10.1097/RHU.0000000000000372
29. De la Hoz JM, Bayona B, Viloria S, et al. (2015) Fatal cases of Chikungunya virus infection in Colombia: diagnostic and treatment challenges. J Clin Virol 69:27–29. doi:10.1016/j.jcv.2015.05.021
30. Economopoulou A, Domínguez M, Helynck B, et al. (2009) Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak in Réunion. Epidemiol Infect 137(4):534–541. doi:10.1017/S0950268808001167
31. Couderc T, Lecuit M (2015) Chikungunya virus pathogenesis: from bedside to bench. Antivir Res 121:120–131. doi:10.1016/j.antiviral.2015.07.002
32. Lohachanakul J, Phuklia W, Thannagith M, et al (2012) High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe Chikungunya fever during the 2009–2010 outbreak in Thailand. Microbiol Immunol 134–138. doi: 10.1111/j.1348-0421.2011.00417.x
33. Rolph MS, Foo SS, Mahalingam S (2015) Emergent chikungunya virus and arthritis in the Americas. Lancet Infect Dis 15(9):1007–1008. doi:10.1016/S1473-3099(15)00231-5
34. Morens DM, Fauci AS (2014) Chikungunya at the door — Déjà vu all over again? N Engl J Med 371(10):885–887. doi:10.1056/NEJMp1408509
35. Vijayakumar K, George B, Anish TS, et al. (2014) Economic impact of chikungunya epidemic: out-of-pocket health expenditures during the 2007 outbreak in Kerala, India. Southeast Asian J Trop Med Public Health 44(1):54–61
36. Pineda C, Caballero-Uribe CV (2015) Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America. Clin Rheumatol 34(Suppl 1):S5–S7. doi:10.1007/s10067-015-3019-6
37. Cardona-Ospina JA, Vera-Polania F, Rodriguez-Morales AJ (2016) Chikungunya or not, differential diagnosis and the importance of laboratory confirmation for clinical and epidemiological research: comment on the article by Rosario et al. Clin Rheumatol 35(3):829–830. doi:10.1007/s10067-015-2995-x
38. WHO. Guidelines for Prevention and Control of Chikungunya Fever 2009. http://www.wpro.who.int/mvp/topics/ntd/Chikungunya_WHO_SEARO.pdf (Accessed July 2016)
39. European Center for Disease Prevention and Control. Chikungunya. http://ecdc.europa.eu/en/healthtopics/chikungunya_fever/Pages/index.aspx (Accessed July 2016)
40. Fernández-Salas I, Danis-Lozano R, Casas-Martínez M, et al. (2015) Historical inability to control Aedes aegypti as main contributor of fast dispersal of chikungunya outbreaks in Latin America. Antivir Res 124:30–42. doi:10.1016/j.antiviral.2015.10.015
41. Vijayan V, Sukumaran S (2016) Chikungunya virus disease: an emerging challenge for the rheumatologist. J Clin Rheumatol 22(4):203–211. doi:10.1097/RHU.0000000000000396
42. American Health Organization/World Health Organization. Number of cumulative cases 2015. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=33091&lang=en